Elixirgen Therapeutics, Inc.

📍 BALTIMORE, United States🗓 Founded 2017👥 13 employees💰 Last funded Jan 2023
Biotechnology🌐 ElixirgenTx.com
Website LinkedIn
Elixirgen Therapeutics is a biotechnology company advancing its controllable self-replicating RNA technology to develop therapies for a broad spectrum of diseases, including rare diseases, aging-related disorders, and cancer. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Elixirgen Therapeutics, Inc.?
Elixirgen Therapeutics, Inc. has 1 investors on record on gritt.io.
When did Elixirgen Therapeutics, Inc. last raise funding?
The most recent investment in Elixirgen Therapeutics, Inc. recorded on gritt.io was in January 2023.
When was Elixirgen Therapeutics, Inc. founded?
Elixirgen Therapeutics, Inc. was founded in 2017.
What industry is Elixirgen Therapeutics, Inc. in?
Elixirgen Therapeutics, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Elixirgen Therapeutics, Inc. based?
Elixirgen Therapeutics, Inc. is headquartered in BALTIMORE, United States.